Journal of Young Pharmacists logo
Article

Discovery of a Series of 5-benzylidene-1, 3-thiazolidine-2, 4-dione-linked Chalcone Hybrids as a Novel Class of 5-Lipoxygenase (5-LO) Inhibitors

1★, 2, 3★ Corresponding author

  1. 1Pharmaceutical Chemistry Division, School of Pharmacy, International Medical University, 126, Jln Jalil Perkasa 19, Bukit Jalil, Wilayah Persekutuan, Kuala Lumpur, MALAYSIA.
  2. 2Pharmacology Division, Faculty of Pharmacy, Asia Metropolitan University, G-8 Jalan Kemacahaya 11, Taman Kemacahaya, Cheras, Selangor, MALAYSIA.
  3. 3Pharmaceutical Chemistry Division, Faculty of Pharmacy, Asia Metropolitan University, G-8 Jalan Kemacahaya 11, Taman Kemacahaya, Cheras, Selangor, MALAYSIA.

CORRESPONDENCE

Vasudeva Rao Avupati

Pharmaceutical Chemistry Division, School of Pharmacy, International Medical University, 126, Jln Jalil Perkasa 19, Bukit Jalil, Wilayah Persekutuan, Kuala Lumpur, MALAYSIA.

Received: 19-10-2017; Revised: 05-12-2017; Accepted: 09-12-2017.

Volume 10, Issue 2 · pp. 241-242 · 2018 · DOI: 10.5530/jyp.2018.10.53

ABSTRACT

In mammals, lipoxygenases (LOXs) are enzymes containing iron that are biological targets for essential fatty acids. These fatty acids are eico sanoids, derived from arachidonic acid, play important roles in im plication and development of multifactorial inflammatory diseases.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Avupati, V. R., Rani, Y., & Singh, A. (2018). Discovery of a Series of 5-benzylidene-1, 3-thiazolidine-2, 4-dione-linked Chalcone Hybrids as a Novel Class of 5-Lipoxygenase (5-LO) Inhibitors. Journal of Young Pharmacists, 10(2), 241-242. https://doi.org/10.5530/jyp.2018.10.53

    Copyright and licence

    © 2018 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0